Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma

Fig. 5

Knockdown of SR-BI inhibited the up-take of HDL-cholesterol. Representative images of ORO staining for ccRCC cells after transfection with siRNA (a). The cholesterol content in ccRCC cells transfected with specific si-SR-BI was much less than control cells (b). The cholesterol content in extracellular media was significantly higher after cells transfection with si-SR-BI (c). *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page
\